StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.52−0.01 (-1.67%)

Close on Nov 17, 2026Market cap $14.24MP/E –Yield –

Citius Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2018 it was 0.0%, against 0.0% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2018Sep 30, 20180.0%+0.0
FY2017Sep 30, 20170.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jun 30, 202667.1%–
Q2 FY2026CQ1 2026Mar 31, 202680.3%–
Q1 FY2026CQ4 2025Dec 31, 202580.0%–

More Citius Pharmaceuticals figures

See a number that looks wrong?